메뉴 건너뛰기




Volumn 57, Issue 9, 2001, Pages 1595-1602

A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients

Author keywords

[No Author keywords available]

Indexed keywords

CITICOLINE; FREE RADICAL; PLACEBO;

EID: 0035856456     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.57.9.1595     Document Type: Article
Times cited : (167)

References (30)
  • 7
    • 0028896412 scopus 로고
    • Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicoline
    • (1995) Life Sci , vol.56 , pp. 637-660
    • Weiss, G.B.1
  • 8
    • 0023872375 scopus 로고
    • Effects of CDP-choline on neurologic deficits and cerebral glucose metabolism in a rat model of cerebral ischemia
    • (1988) Stroke , vol.19 , pp. 217-222
    • Kakihana, M.1    Fukuda, N.2    Suno, M.3
  • 19
    • 0023860168 scopus 로고
    • Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study
    • (1988) Stroke , vol.19 , pp. 211-216
    • Tazaki, Y.1    Sakai, F.2    Otomo, E.3
  • 27
    • 0028783948 scopus 로고
    • Tissue plasminogen activator for acute ischemic stroke
    • (1995) N Engl J Med , vol.333 , pp. 1581-1587
  • 28
    • 0032541845 scopus 로고    scopus 로고
    • Randomized double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASSII)
    • (1998) Lancet , vol.352 , pp. 1245-1251
    • Hacke, W.1    Kaste, M.2    Fieshchi, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.